Design
Review
Authors
Loading...
Chymase inhibition merits targeted study in ischemic disease; leaves open clinical relevance beyond ACE blockade.
Key points are not available for this paper at this time.
H Urata (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: